Nanovibrational stimulation of mesenchymal stem cells induces therapeutic reactive oxygen species and inflammation for 3D bone tissue engineering
preprint
OA: closed
Abstract
ABSTRACT There is a pressing clinical need to develop cell-based bone therapies due to a lack of viable, autologous bone grafts and a growing demand for bone grafts in musculoskeletal surgery. Such therapies can be tissue engineered and cellular, such as osteoblasts combined with a material scaffold. Because mesenchymal stem cells (MSCs) are both available and fast growing compared to mature osteoblasts, therapies that utilise these progenitor cells are particularly promising. We have developed a nanovibrational bioreactor that can convert MSCs into bone-forming osteoblasts in 2D and 3D but the mechanisms involved in this osteoinduction process remain unclear. Here, to elucidate this mechanism, we use increasing vibrational amplitude, from 30 nm (N30) to 90 nm (N90) amplitudes at 1000 Hz, and assess MSC metabolite, gene and protein changes. These approaches reveal that dose-dependent changes occur in MSCs’ responses to increased vibrational amplitude, particularly in adhesion and mechanosensitive ion channel expression, and that energetic metabolic pathways are activated, leading to low-level reactive oxygen species (ROS) production and to low-level inflammation, as well as to ROS- and inflammation-balancing pathways. These events are analogous to those that occur in the natural bone-healing processes. We have also developed a tissue engineered MSC-laden scaffold designed using cells’ mechanical memory, driven by the stronger N90 stimulation. These new mechanistic insights and cell-scaffold design are underpinned by a process that is free of inductive chemicals.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
References (52)
- doi:10.2106/jbjs.j.01513 via crossref
- doi:10.1016/j.injury.2011.06.015 via crossref
- doi:10.1016/j.stem.2018.05.004 via crossref
- doi:10.1038/nm.3028 via crossref
- doi:10.1007/978-1-4939-8997-3_4 via crossref
- doi:10.1016/j.mce.2008.02.017 via crossref
- doi:10.1021/nn400202j via crossref
- doi:10.1038/s41551-017-0127-4 via crossref
- doi:10.1038/s41598-019-49422-4 via crossref
- doi:10.1038/nmat4051 via crossref
- doi:10.1016/j.cell.2006.06.044 via crossref
- doi:10.1098/rsta.1965.0051 via crossref
- doi:10.1210/edrv-14-4-424 via crossref
- doi:10.1021/nn504767g via crossref
- doi:10.1038/nature02196 via crossref
- doi:10.1016/j.cmet.2008.08.002 via crossref
- doi:10.1073/pnas.1414298111 via crossref
- doi:10.1073/pnas.1312477110 via crossref
- doi:10.1038/nature13250 via crossref
- doi:10.1177/2041731418808695 via crossref
- doi:10.1016/j.semcdb.2017.06.018 via crossref
- doi:10.3389/fphar.2019.01304 via crossref
- doi:10.1126/science.1215637 via crossref
- doi:10.1074/jbc.m800021200 via crossref
- doi:10.1111/jcmm.13356 via crossref
- doi:10.1089/scd.2014.0484 via crossref
- doi:10.1073/pnas.0903269107 via crossref
- doi:10.1038/natrevmats.2017.91 via crossref
- doi:10.1083/jcb.200610046 via crossref
- doi:10.1097/wox.0b013e3182439613 via crossref
- doi:10.1634/stemcells.2007-0509 via crossref
- doi:10.1016/j.biochi.2014.10.004 via crossref
- doi:10.1016/j.cell.2016.08.064 via crossref
- doi:10.1016/j.bone.2016.02.020 via crossref
- doi:10.1038/sj.cdd.4401830 via crossref
- doi:10.1016/j.molmed.2009.06.005 via crossref
- doi:10.1101/cshperspect.a016295 via crossref
- doi:10.1084/jem.178.6.2207 via crossref
- doi:10.1002/jemt.22631 via crossref
- doi:10.1016/j.bbadis.2007.03.003 via crossref
- doi:10.1126/stke.2722005re3 via crossref
- doi:10.1016/j.cell.2017.10.008 via crossref
- doi:10.1038/nmat3889 via crossref
- doi:10.1074/jbc.m113.528638 via crossref
- doi:10.1038/s41598-017-18089-0 via crossref
- doi:10.1016/j.celrep.2017.05.079 via crossref
- doi:10.1146/annurev-neuro-070918-050509 via crossref
- doi:10.1002/jcp.22605 via crossref
- doi:10.1089/scd.2016.0315 via crossref
- doi:10.1042/bj20081386 via crossref
- doi:10.1038/s41551-017-0127-4 via crossref
- doi:10.1006/meth.2001.1262 via crossref
Source provenance
- crossref
- last seen: 2026-07-06T06:38:57.720390+00:00
- europepmc
- last seen: 2026-05-19T01:45:01.086888+00:00
- unpaywall
- last seen: 2026-08-01T06:38:12.426807+00:00